AMRX Other | AMNEAL PHARMACEUTICALS, INC.

AMNEAL PHARMACEUTICALS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2024-03-14: Form 10-K; Item Well-known seasoned issuer; As filed No.
2023-11-09: Form 10-Q; Item Shares outstanding CommonClassA as of 2023-11-07; As filed 306,544,199.
2023-11-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Class A Common Stock, par value $0.01 per share · AMRX · NYSE.
2023-08-08: Form 10-Q; Item Shares outstanding CommonClassA as of 2023-07-31; As filed 154,194,960.

Filed	Form	Item	As filed
2024-03-14	10-K	Well-known seasoned issuer	No
2023-11-09	10-Q	Shares outstanding CommonClassA as of 2023-11-07	306,544,199
2023-11-09	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2023-08-08	10-Q	Shares outstanding CommonClassA as of 2023-07-31	154,194,960
2023-08-08	10-Q	Shares outstanding CommonClassB as of 2023-07-31	152,116,890
2023-08-08	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2023-05-09	10-Q	Shares outstanding CommonClassA as of 2023-04-30	153,337,273
2023-05-09	10-Q	Shares outstanding CommonClassB as of 2023-04-30	152,116,890
2023-05-09	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2023-03-03	10-K	Shares outstanding CommonClassA as of 2023-02-14	151,500,830
2023-03-03	10-K	Shares outstanding CommonClassB as of 2023-02-14	152,116,890
2023-03-03	10-K	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2023-03-03	10-K	Well-known seasoned issuer	No
2022-11-07	10-Q	Shares outstanding CommonClassA as of 2022-10-28	151,475,789
2022-11-07	10-Q	Shares outstanding CommonClassB as of 2022-10-28	152,116,890
2022-11-07	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2022-08-08	10-Q	Shares outstanding CommonClassA as of 2022-07-25	151,408,535
2022-08-08	10-Q	Shares outstanding CommonClassB as of 2022-07-25	152,116,890
2022-08-08	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2022-05-06	10-Q	Shares outstanding CommonClassA as of 2022-04-25	150,807,252
2022-05-06	10-Q	Shares outstanding CommonClassB as of 2022-04-25	152,116,890
2022-05-06	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2022-03-01	10-K	Shares outstanding CommonClassA as of 2022-02-14	149,424,272
2022-03-01	10-K	Shares outstanding CommonClassB as of 2022-02-14	152,116,890
2022-03-01	10-K	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2021-11-08	10-Q	Shares outstanding CommonClassA as of 2021-10-29	149,371,355
2021-11-08	10-Q	Shares outstanding CommonClassB as of 2021-10-29	152,116,890
2021-11-08	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2021-08-09	10-Q	Shares outstanding CommonClassA as of 2021-07-30	149,277,872
2021-08-09	10-Q	Shares outstanding CommonClassB as of 2021-07-30	152,116,890
2021-08-09	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2021-05-07	10-Q	Shares outstanding CommonClassA as of 2021-04-30	148,720,537
2021-05-07	10-Q	Shares outstanding CommonClassB as of 2021-04-30	152,116,890
2021-05-07	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2021-03-01	10-K	Shares outstanding CommonClassA as of 2021-02-12	147,704,364
2021-03-01	10-K	Shares outstanding CommonClassB as of 2021-02-12	152,116,890
2021-03-01	10-K	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2020-11-06	10-Q	Shares outstanding CommonClassA as of 2020-10-31	147,628,440
2020-11-06	10-Q	Shares outstanding CommonClassB as of 2020-10-31	152,116,890
2020-11-06	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2020-08-06	10-Q	Shares outstanding CommonClassA as of 2020-07-31	147,539,347
2020-08-06	10-Q	Shares outstanding CommonClassB as of 2020-07-31	152,116,890
2020-08-06	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2020-05-11	10-Q	Shares outstanding CommonClassA as of 2020-04-30	147,314,497
2020-05-11	10-Q	Shares outstanding CommonClassB as of 2020-04-30	152,116,890
2020-05-11	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2020-03-02	10-K	Shares outstanding CommonClassA as of 2020-02-13	147,109,015
2020-03-02	10-K	Shares outstanding CommonClassB as of 2020-02-13	152,116,890
2020-03-02	10-K	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2019-11-07	10-Q	Stock registered under Section 12(b)	Class A Common Stock, par value $0.01 per share · AMRX · NYSE
2019-03-01	10-K	Well-known seasoned issuer	No
2018-03-09	10-K	Current in its reporting	No
2018-03-09	10-K	Well-known seasoned issuer	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Liquidia Corp (LQDA)	United States	$6.347B	51.23
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20
Alkermes plc. (ALKS)		$6.844B	132.74
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07